Skip Navigation Bar
John B. Calhoun Papers 1909-1996
full text File Size: 1862 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Series 6: Consulting Work, 1974-1988 [series]:
 
2-Nitropropane (2-NP) [subseries]:
14 27-28
Background Information, 1977-1979
 
Covington and Burling [subseries]:
14 29
Contracts and Invoices, 1979
14 30
Correspondence, 1978-1979
14 31
Mantel Reports, 1978-1979
 
International Minerals and Chemical Corporation [subseries]:
14 32
Contracts and Invoices, 1979
14 33
Correspondence, 1978
14 34
Keller and Heckman - correspondence, 1979
 
2, 4, 5-Trichlorophenoxyacetic acid (2,4,5-T) and Silvex [subseries]:
14 35
Background Information, 1979
15 1-5
Background Information, 1979
15 6
Testimony and Affidavits - Mantel, Nathan, 1979
15 7
Arnold and Porter - correspondence, 1979
 
National Forest Products Association [subseries]:
15 8
Contracts and Invoices, 1979
15 9
Correspondence, 1979
15 10
Mantel Reports, 1979
15 11
4-chloro-0-toluidine-HCL - background information, 1977
 
Acetaminophen [subseries]:
15 12
Background information, 1981
 
Simpson, Thacher, and Bartlett [subseries]:
15 13
Contracts and Invoices, 1982
15 14
Correspondence, 1981
15 15
Mantel Reports, 1982
 
Acrylates [subseries]:
15 16-17
Background Information, 1988
 
Battelle Memorial Institute [subseries]:
15 18
Contracts and Invoices, 1986
15 19
Correspondence, 1987
15 20
Mantel Reports, 1986-1987
 
Washington Environmental Program Office [subseries]:
15 21
Contracts and Invoices, 1986
15 22
Mantel Reports, undated
 
Acrylonitrile [subseries]:
16 1-2
Background Information, 1977
16 3
Testimony and Affidavits - Mantel, Nathan, 1977
 
Keller and Heckman [subseries]:
16 4
Contracts and Invoices, 1977-1978
16 5
Correspondence, 1977
16 6
Mantel Reports, 1977
 
Natural Resourses Defense Council, Inc. [subseries]:
16 7
Contracts and Invoices, 1977
16 8
Mantel Reports, 1977
 
Pepper, Hamilton, and Scheetz [subseries]:
16 9
Contracts and Invoices, 1978
16 10
Correspondence, 1978
16 11
Mantel Reports, undated
16 12
Actifed - background information, 1982
16 13
Aflatoxin (Velsicol) - background information, 1976-1978
 
Aftate [subseries]:
16 14
Background Information, 1979
 
Wald, Harkrader, and Ross [subseries]:
16 15
Contracts and Invoices, 1979
16 16
Correspondence, 1979
16 17
Mantel Reports, 1979
 
Airborne Arsenic [subseries]:
16 18-20
Background Information, 1980-1981
16 21
American Public Health Association - Mantel reports, 1975
 
American Smelting and Refining Company (ASARCO) [subseries]:
16 22
Contracts and Invoices, 1980
16 23
Mantel Reports, 1980
 
Chemical Manufacturers Association [subseries]:
16 24
Contracts and Invoices, 1982
16 25
Correspondence, 1982
16 26
Mantel reports, 1982
16 27
Koppers Company - correspondence, 1982
 
Alcohol and Breast Cancer [subseries]:
16 28-29
Background Information, 1987
16 30
Distilled Spirits Council of the United States - correspondence, 1987
 
Licensed Beverage Information Council [subseries]:
16 31
Correspondence, 1987
17 1
Mantel Reports, c.1987
17 2
Weil, Gotshal, and Manges - Mantel reports, undated
 
Aldrin, Dieldrin and DDT [subseries]:
17 3
Background Information, 1974
17 4
Testimony and Affidavits - Mantel, undated
 
Environmental Protection Agency [subseries]:
17 5
Contracts and Invoices, 1974
17 6
Mantel Reports
17 7
Goodwin and Hawthorn - correspondence, 1975
17 8
Keller and Heckman - correspondence, 1977
 
Alpo Petfoods v. Ralston Purina Co. [subseries]:
17 9-19
Background Information, 1988
17 20
Testimony and Affidavits - Mantel, Nathan, 1988
17 21
Leighton and Regnery - Mantel reports, 1988
 
Sutherland, Asbill, and Brennan [subseries]:
17 22
Correspondence, 1988
17 23
Mantel Reports, 1988
 
Ambient SO2 [subseries]:
17 24
Background Information, 1982
17 25
Shea and Gardner - contracts and invoices, 1982
 
Aminorex Fumarate [subseries]:
17 26
Background Information, 1976-1977
18 1-2
Background Information (cont'd), 1976-1966
 
Cilag-Chemie [subseries]:
18 3
Correspondence, 1977
18 4
Mantel Reports, 1977
 
Johnson and Johnson [subseries]:
18 5
Contracts and Invoices, 1977
18 6
Correspondence, 1977
 
McNeil Pharmaceutical [subseries]:
18 7
Contracts and Invoices, 1976
18 8
Correspondence, 1976
18 9
Mantel Reports, 1976
 
Arprinocid (MK-302) [subseries]:
18 10
Background Information, 1981
 
Merck, Sharp, and Dohme [subseries]:
18 11
Contracts and Invoices, 1983
18 12
Mantel Reports, 1983
 
Azo Gantanol [subseries]:
18 13-14
Background Information, 1976
18 15
Testimony and Affidavits - Mantel, Nathan, 1976
 
Hoffman LaRoche, Inc. [subseries]:
18 16
Contracts and Invoices, 1976-1978
18 17
Correspondence, 1977
 
Ortho Pharmaceutical Corporation [subseries]:
18 18
Contracts and Invoices, 1976
18 19
Correspondence, 1976
 
Bendectin [subseries]:
18 20-21
Background Information, undated
 
Dinsmore and Shohl [subseries]:
18 22
Contracts and Invoices, 1986
18 23
Correspondence, 1986
18 24
Mantel Reports, c.1986
 
Paulson, Nace, and Norwind
18 25
Contracts and Invoices, 1986
18 26
Correspondence, 1986
 
Bentyl [subseries]:
18 27-28
Background Information, 1979
 
Bio/Basics International [subseries]:
18 29
Contracts and Invoices, 1978
18 30
Correspondence, 1979
18 31
Mantel Reports, 1979
 
Benzyl Acetate [subseries]:
18 32
Background Information, 1983
18 33
Testimony and Affidavits - Mantel, 1983
 
Flavor and Extract Manufacturers' Association [subseries]:
18 34
Contracts and Invoices, 1983
18 35
Mantel Reports, 1983
 
Butrimovitz v. Schering Corporation [subseries]:
18 36
Henry R. Simon - contracts and invoices, 1983
 
Cambendazole [subseries]:
18 37
Background Information, 1978
 
Merck, Sharp, and Dohme [subseries]:
18 38
Contracts and Invoices, 1978
18 39
Mantel Reports, undated
18 40
Carbon Disulfide - background information, 1985
18 41
Chloramphenicol - background information, undated
 
Chlordimeform [subseries]:
 
Schering AG [subseries]:
18 42
Correspondence, 1977-1978
18 43
Mantel Reports, 1978
 
Cimetidine / Tagamet [subseries]:
18 44
Background Information, 1986
 
Smith, Kline, and French Laboratories [subseries]:
18 45
Contracts and Invoices, 1987
18 46
Correspondence, 1987
18 47
Mantel Reports, 1987
 
Cofisc Material [subseries]:
18 48
GWU Biostatistics Center - contracts and invoices, 1976
 
Cronassial [subseries]:
18 49
[unknown entity] - Mantel reports, undated
 
Cyclospasmol [subseries]:
19 1-5
Background Information, 1983-1985
19 6
Testimony and Affidavits - Mantel, Nathan, undated
19 7
Arnold and Porter - correspondence, 1985-1986
 
Ives Laboratories, Inc. [subseries]:
19 8
Contracts and Invoices, 1985
19 9
Correspondence, 1985
19 10
Mantel Reports, 1985
 
Dantrium [subseries]:
19 11
Norwich Pharmacal - correspondence, 1975
19 12
Merck, Sharp, and Dohme - correspondence, 1975
 
Diethylstilbestrol (DES) [subseries]:
19 13-16
Background Information, undated, 1972
 
Testimony and Affidavits [subseries]:
19 17
Herbst, Arthur L., 1982
19 18
Stolley, Dr., undated
19 19
Swan, Shanna Helen, 1980-1982
20 1-5
Swan, Shanna Helen (cont'd), 1980-1982
20 6
Covington and Burling - correspondence, 1977
20 7
Crosby, Heafey, Roach, and May - correspondence, 1982
20 8
Kleinfeld, Kaplan, and Becker - correspondence, 1977
 
Shanley and Fisher [subseries]:
20 9
Correspondence, 1986
20 10
Mantel Reports, 1986
20 11
Henry R. Simon - contracts and invoices, 1983
 
Dioxin (2, 3, 7, 8-tetrachlorodibenzo) [subseries]:
20 12-15
Background Information, 1979-1984
21 1-10
Background Information (cont'd), 1979-1984
 
Regione Lombardia International Steering Committee [subseries]:
21 11
Correspondence, 1979-1981
21 12
Mantel Reports, undated
 
Ditlow Affidavit [subseries]:
21 13
Background Information, 1985
21 14
Testimony and Affidavits - Mantel, Nathan, 1985
 
Dose Response Data [subseries]:
21 15
Bio-Dynamics, Inc. - contract and invoices, 1983
 
Drug 47-603 [subseries]:
21 16
Background Information, 1977
 
Sandoz [subseries]:
21 17
Correspondence, 1977
21 18
Mantel Reports, 1977
 
Ethylene Dibromide [subseries]:
22 1-2
Background Information, 1980-1984
 
Florida Department of Citrus [subseries]:
22 3
Contracts and Invoices, 1981
22 4
Correspondence, 1981
22 5
Mantel Reports, 1981
 
FDA proposal of criteria and procedures for evaluating assays for carcinogenic residues (in edible products of animals) [subseries]:
22 6-8
Background Information, 1977-1983
 
Testimony and Affidavits [subseries]:
22 9
Mantel, Nathan, 1977
22 10
Sieck, Robert F., 1977
 
Animal Health Institute [subseries]:
22 11
Contracts and Invoices, 1979
22 12
Correspondence, 1979
22 13
Mantel Reports, 1979
 
Covington and Burling [subseries]:
22 14
Contracts and Invoices, 1977
22 15
Mantel Reports, 1977
22 16
Norwich Pharmacal - contracts and invoices, 1977
22 17
Flutamide - Schering-Plough Corporation - contracts and invoices, 1917
 
Furazolidone (NF-180) [subseries]:
22 18-20
Background Information, 1975-1977
 
Testimony and Affidavits [subseries]:
22 21
Bickerton, Robert K., 1977
22 22
Heotis, James P., 1975
22 23
Mantel, Nathan, 1975
22 24
Touchstone, Joseph C., undated
22 25
Kleinfield, Kaplan, and Becker - correspondence, 1976
 
Norwich Pharmacal [subseries]:
22 26
Contracts and Invoices, 1975-1978
22 27
Correspondence, 1975
22 28
Mantel Reports, 1975
 
Gangliosides [subseries]:
22 29
Background Information, 1984
22 30
Bio/Basics International - contracts and invoices, 1984
 
Heptachlor-Chlordane [subseries]:
22 31
Background Information, undated
23 1
Background Information (cont'd), undated
 
Testimony and Affidavits [subseries]:
23 2
Carlborg, Frank William, undated
23 3
Jones, Hardin B., undated
23 4
Kutz, Frederick W., undated
23 5
Mantel, Nathan
23 6
EPA Office of General Counsel for Pesticides - contracts and invoices, 1975
23 7
Williams, Connoly, and Califano - contracts and invoices, undated
 
ICP test for sero-diagnosis of cancer [subseries]:
 
Jack Freund [subseries]:
23 8
Contracts and Invoices, 1979
23 9
Correspondence, 1979
23 10
Mantel Reports, 1979
 
"Identification and specification of inputs for benefit cost modeling of pesticide use" [subseries]:
23 11
Pennsylvania State University, Center for Study of Environmental Policy - Mantel reports, 1977
 
Indapamide [subseries]:
 
USV Laboratories [subseries]:
23 12
Contracts and Invoices, 1980
23 13
Correspondence, 1980
23 14
Mantel Reports, 1980
 
Iodochlorhydroxyquin and Hydrocortisone [subseries]:
23 25-16
Background Information, 1985
 
Testimony and Affidavits [subseries]:
23 17
Eaglestein, William H., undated
23 18
Johnson, Mary F., undated
23 19
Mantel, Nathan, undated
23 20
Rosenberg, E. William, undated
23 21
Solomon, Lawrence F., undated
 
Isoprinosine / Inosiplex [subseries]:
23 22-29
Background Information, 1979-1981
24 1
Background Information (cont'd), 1979-1981
24 2
Testimony and Affidavits - Mantel, Nathan, undated
 
Newport Pharmaceuticals International [subseries]:
24 3
Contracts and Invoices, 1982
24 4
Correspondence, 1981
24 5
Mantel Reports, undated
 
Limulus Amebocyte Lysate [subseries]:
24 6
Background Information, undated
 
Mawalan and Warrington
24 7
Contracts and Invoices, undated
24 8
Mantel Reports, undated
24 9
Millipore - Mantel reports, 1978
24 10
Worthington Biochemical Corporation - contracts and invoices, 1978-1979
 
Manson v. Bristol Myers [subseries]:
24 11
Kersten and McKinnon - correspondence, 1986
 
Mirex [subseries]:
 
Testimony and Affidavits [subseries]:
24 12
Gart, John, Jr., 1974
24 13
Gross, M. Adrian, 1973
24 14
Mantel, Nathan, 1975
24 15
Reuber, Melvin D., 1973
 
MK-231 (Sulindac) [subseries]:
24 16
Merck, Sharp, and Dohme - Mantel reports, 1974
 
MK-930 (Ronidazole) [subseries]:
24 17
Background Information, 1977
 
Merck, Sharp, and Dohme [subseries]:
24 18
Contracts and Invoices, 1981
24 19
Correspondence, 1977
24 20
Mantel Reports, undated
 
Modifications of the Mantel-Bryan procedure [subseries]:
24 21
Merck, Sharp, and Dohme - contracts and invoices, 1974
 
N-nitrosopyrrolidine (Npyr) [subseries]:
24 22
Background Information, 1978
 
American Meat Institute [subseries]:
24 23
Contracts and Invoices, 1978
24 24
Mantel Reports, 1978
24 25
Kleinfield, Kaplan, and Becker - Mantel reports, undated
24 26
Neuroleptics and Breast Cancer - McNeil Laboratories, Inc. - contracts and invoices, 1978
 
OSHA Proposed regulations for identification, classification and regulation of toxic substances posing a potential occupational carcinogenic risk to humans [subseries]:
24 27
Background Information, undated
 
Testimony and Affidavits [subseries]:
24 28
Gross, M. Adrian, 1978
24 29
Peto, Richard, 1978
24 30
Occupational Safety and Health Administration - correspondence, 1978
 
Oxford Survey of Childhood Cancers [subseries]:
24 31
Background Information, 1975
 
Food and Drug Administration [subseries]:
24 32
Contracts and Invoices, 1974-1975
24 33
Mantel Reports, undated
 
Paraflex and Parafon [subseries]:
24 34
Background Information, 1980-1983
24 35
Testimony and Affidavits - Mantel, Nathan, 1982
 
McNeil Pharmaceutical [subseries]:
24 36
Contracts and Invoices, 1982
24 37
Correspondence, 1982
24 38
Mantel Reports, 1982
 
Passive Smoking Effects [subseries]:
24 39-40
Background Information, 1981-1986
24 41
Testimony and Affidavits - Mantel, Nathan, 1987
 
Tobacco Institute [subseries]:
24 42
Contracts and Invoices, 1981
24 43
Mantel Reports, 1981
 
Pathibamate [subseries]:
 
Wald, Harkrader, and Ross [subseries]:
24 44
Contracts and Invoices, 1983
24 45
Correspondence, 1983
24 46
Permethrin - background information, undated
 
Polybrominated Biphenyl (PCB) [subseries]:
25 1-4
Background Information, 1975
 
Testimony and Affidavits [subseries]:
25 5
Allen, James R., 1975
25 6
Blumenthal, Herbert, 1975
25 7
Corneliussen, Paul E., 1975
25 8
Gilbert, Seymour, 1975
25 9
Keplinger and Moreno, undated
25 10
Kimbrough, Renate D., 1975
25 11
Kolbye, Albert C., Jr., 1975
25 12
Mantel, Nathan, undated
25 13
Wessel, John R., 1975
 
Wald, Harkrader, and Ross [subseries]:
25 14
Contracts and Invoices, undated
25 15
Correspondence, 1975
25 16
Mantel Reports, 1975
 
Polydioxanone [subseries]:
 
Ethicon [subseries]:
25 17
Contracts and Invoices, 1981
25 18
Mantel Reports, 1981
25 19
Propylene Oxide - background information, 1983
 
Radiation and Surgery in Treatment of Breast Cancer [subseries]:
25 20
Background Information, undated
25 21
Ludwig Institut fur Krebsforschung - contracts and invoices, 1977
 
Red Dye No. 40 [subseries]:
25 22-26
Background Information, 1978-1979
 
Cosmetic, Toiletry and Fragrance Association [subseries]:
25 27
Contracts and Invoices, 1980
25 28
Correspondence, 1980
25 29
Mantel Reports, 1980
 
Emmes Corporation [subseries]:
25 30
Correspondence, 1980
25 31
Mantel Reports, 1979-1980
 
Food and Drug Administration [subseries]:
25 32
Correspondence, 1978-1979
25 33
Mantel Reports, 1979
 
Merck, Sharp, and Dohme [subseries]:
25 34
Correspondence, 1978
25 35
Mantel Reports, 1978
 
Resmethrin [subseries]:
25 36
Background Information, 1981
 
Penick Corporation [subseries]:
26 1
Contracts and Invoices, 1980
26 2
Mantel Reports, 1980
 
Reye's Syndrome and Aspirin [subseries]:
26 3
Background Information, undated
 
Testimony and Affidavits [subseries]:
26 4
Mantel, Nathan, 1982
26 5
Wolfe, Sidney M., 1982
 
Schering-Plough Corporation [subseries]:
26 6
Contracts and Invoices, 1982
26 7
Correspondence, 1982
26 8
Mantel Reports, 1982
 
Saccharin [subseries]:
26 9
Background Information, 1979
26 10
Testimony and Affidavits - Wolfe, Sidney W.; Johnson, Anita, 1977
 
"Safe" Levels [subseries]:
 
Arnold and Porter [subseries]:
26 11
Contracts and Invoices, 1977
26 12
Correspondence, 1976
 
Ortho Pharmaceutical Corporation [subseries]:
26 13
Correspondence, 1976
26 14
Mantel Reports, undated
 
Schering AG [subseries]:
26 15
Contracts and Invoices, 1977-1978
26 16
Correspondence, 1978
26 17
Mantel reports, 1977
 
Smith Hall, Rutgers [subseries]:
26 18-20
Background Information, 1986
 
Morgan, Melhuish, Mowaghan, Arvidson, Abrutin, and Lisowski
 
Statistical Consulting [subseries]:
 
Abbott Laboratories [subseries]:
26 23
Contracts and Invoices, 1980
26 24
Correspondence, 1980
 
American Health Foundation [subseries]:
26 25
Contracts and Invoices, 1986
26 26
Mantel Reports, 1986
26 27
Hoffman LaRoche, Inc. - correspondence, 1976
 
McNeil Laboratories, Inc. [subseries]:
26 28
Contracts and Invoices, 1977-1983
26 29
Correspondence, 1983
26 30
Crosby, Heafey, Roach, and May - contracts and invoices, 1982
 
Ebon Research Systems [subseries]:
26 31
Background Information, undated
26 32
Contracts and Invoices, 1980
26 33
Correspondence, 1980
26 34
Grier, Swartzman, and Weiner - contracts and invoices, 1984
 
Merck, Sharp, and Dohme [subseries]:
26 35
Correspondence, 1980-1981
26 36
Contracts and Invoices, 1980
26 37
Moshman Associates - contracts and invoices, 1985
26 38
Norwich Pharmacal - contracts and invoices, 1977-1978
26 39
Sandoz Pharmaceuticals - contracts and invoices, 1978
 
Swine Flu Vaccine and Guillain-Barre Syndrome [subseries]:
26 40-46
Background Information, 1980-1986
 
Testimony and Affidavits [subseries]:
27 1
Bear, Donald Vantwisk, 1980
27 2
Langmuir, Alexander P., 1979
27 3
Saxon, Andrew, 1980
27 4-6
Schonberger, Lawrence, 1979
27 7
Center for Disease Control - correspondence, 1981-1982
 
Grier, Swartzman, and Weiner [subseries]:
27 8
Contracts and Invoices, 1981
27 9
Correspondence, 1982
27 10
Mantel Reports, undated
 
U.S. Department of Justice [subseries]:
27 11
Contracts and Invoices, 1983
27 12
Correspondence
27 13
Temazepam - Sandoz Pharmaceuticals - Mantel reports, 1977
27 14
Timolol (MK-950) - Merck, Sharp, and Dohme - Mantel reports, 1974
 
Titanium Dioxide [subseries]:
 
Merck, Sharp, and Dohme [subseries]:
27 15
Contracts and Invoices, 1978
27 16
Mantel Reports, 1978
 
Today Contraceptive Sponge / 2,4-Toluenediamine [subseries]:
27 17-18
Background Information, 1983, undated
 
Testimony and Affidavits [subseries]:
27 19
Hayes, Arthur Hull, Jr., 1983
27 20
Mantel, Nathan, 1983
27 21
Vorhauer, Bruce W., 1983
27 22
House Subcommittee on Intergovernmental Relations and Human Resources - Mantel reports, 1983
 
Tolmetin [subseries]:
27 23
Background Information, 1981
 
McNeil Pharmaceutical [subseries]:
27 24
Contracts and Invoices, 1981
27 25
Mantel Reports, 1981
 
Toxic Shock Syndrome and Tampons [subseries]:
 
Wald, Harkrader, and Ross [subseries]:
27 26
Contracts and Invoices, 1980
27 27
Correspondence, 1980
27 28
Mantel Reports, 1980
27 29-30
Trental (Pentoxifylline) - background information, 1985
 
Urinary Tract Infection Treatment [subseries]:
27 31
Hoffman LaRoche, Inc. - correspondence, 1976
27 32
Vinyl Chloride - background information, 1975
 
Vioform-Hydrocortisone [subseries]:
27 33-34
Background Information, 1985
 
Sutherland, Asbill, and Brennan [subseries]:
27 35
Correspondence, 1985
28 1
Mantel Reports, 1985
 
Wald, Harkrader, and Ross [subseries]:
28 2
Contracts and Invoices, 1985
28 3
Correspondence, 1984
28 4
Mantel Reports, 1985
 
Water Quality [subseries]:
28 5
Background Information, 1983
28 6
Dynamac Corporation - correspondence, 1982
 
Hunton and Williams [subseries]:
28 7
Contracts and Invoices, 1983
28 8
Correspondence, 1983
28 9
Mantel Reports, undated
 
Zimelidine [subseries]:
28 10
Background Information, 1981
28 11
Merck, Sharp, and Dohme - Mantel reports, 1981
 
Zomax [subseries]:
 
McNeil Pharmaceutical [subseries]:
28 12
Contracts and Invoices, 1981
28 13
Mantel Reports, 1983